As ACE2 is a negative regulator of ACE, it is possible that the development of anti-ACE2 autoantibodies has a role in COVID-19 pathogenesis, resulting in tissue edema, inflammation, and damage exacerbated. This evidence concerns the gene ACE2 and COVID-19.